• Everyday Alpha
  • Posts
  • The Overlooked Regional Bank Story That Still Looks Mispriced

The Overlooked Regional Bank Story That Still Looks Mispriced

Investors spent years avoiding smaller regional banks at almost any cost. Now, one overlooked banking name is beginning to show signs that the fear trade may finally be fading.

There are still corners of the regional banking sector trading like the crisis never ended. That disconnect is exactly what makes this recovery story increasingly difficult to ignore.

Policy Impact (Sponsored)

The U.S. government pumped more than $1 billion into Intel.

The stock popped 128%. It pumped $400 million into MP Materials.

The stock popped 200%. It bought 10% of Trilogy Metals.

The stock popped 500%.

And now, Trump has chosen this AI stock for a $1 billion payday.

Click here for the full story and stock pick (free).

Carter Bankshares, Inc. 

May 18 – Pre‑market
Ticker: CARE | Sector: Banks - Regional / Financial Services | Market Cap: $580.8B

30‑Second Take

A growing divide is opening up within regional banking right now.

Investors have largely piled back into the biggest names, while several smaller, community-focused banks are still trading as if the sector never recovered from the 2023 banking panic.

That disconnect is exactly what makes Carter Bankshares interesting.

The company is showing signs of improving profitability, stronger loan growth discipline, and steadier balance sheet performance, at a time when sentiment toward smaller banks is slowly thawing.

If interest rate pressure eases further and confidence continues returning to regional financials, CARE looks like one of those overlooked recovery stories the market may have left behind for too long.

Trade Setup

Time frame: Medium-term 
Edge type: Sentiment disconnect meets operational stabilization

A large part of the market still treats smaller regional banks as damaged assets after the sector-wide panic of the last two years. CARE is starting to look different, with improving fundamentals creating room for a rerating.

IPO Filing Shock (Sponsored)

It was supposed to be confidential...

Right now, 21 banks are lining up to underwrite the $1.75 TRILLION deal - JPMorgan, Goldman Sachs, Morgan Stanley.

June is the target date for launch...

That gives everyday Americans a small window to get positioned before Wall Street insiders gobble up all the profits.

Trivia: If you had invested $1,000 in Berkshire Hathaway when Warren Buffett took control in 1965, what would it be worth today?

Login or Subscribe to participate in polls.

Snapshot Table

Metric

Value

Current Stance

Price

$26.14

Average

52‑week range

$15.40 - $27.24

Average

Short interest

4.43%

Average

Next catalyst

Deposit stability update

Chart

1-month trading summary: CARE has spent the last month moving steadily higher, climbing just over 8% while quietly pushing toward the upper end of its 52-week range. The move has not been explosive, but that is part of what makes it interesting.

This looks less like speculative momentum and more like investors slowly reassessing a regional bank that still trades at a surprisingly modest valuation relative to its earnings profile.

The chart also suggests buyers have consistently stepped in on dips rather than chasing short-lived spikes.

For a smaller regional bank, that kind of controlled upward trend often matters more than headline volatility, because it points to confidence gradually rebuilding beneath the surface.

Bull Case 

The banking recovery trade hiding in plain sight: For the past few years, smaller regional banks have been treated as if their entire business model had permanently broken.

Deposit flight fears, commercial real estate concerns, and higher funding costs pushed investors toward the largest financial institutions, leaving many community banks behind, regardless of individual execution.

CARE still appears partially trapped in that sentiment overhang, despite strong profitability metrics and a valuation that already prices in significant caution.

What makes this setup interesting is that the business itself appears far steadier than the market narrative around small banks.

The company maintains a conservative community banking model, continues to generate earnings, and trades at a remarkably low earnings multiple relative to the broader market.

If the rate environment becomes even modestly more supportive, smaller banks with stable deposit bases and disciplined lending books could see sentiment improve far faster than you might expect.

Making the market pay attention: The biggest catalyst for Carter is continued evidence that profitability remains resilient even in a difficult regional banking environment.

If margins stabilize further and loan performance remains healthy, the market narrative around smaller banks becomes much harder to justify.

There is also a broader sector dynamic working in CARE's favor.

Expectations for lower interest rates over time could ease pressure on funding costs across regional banking, helping investors rotate back into smaller financial names that were heavily discounted during the banking stress cycle.

Because CARE still trades at a relatively low valuation, even a modest improvement in sentiment could have an outsized impact on its price.

More miles in the tank: The current Wall Street target range of $27.00 - $28.00 suggests further upside from here, and that may still prove conservative if sentiment toward smaller regional banks improves more aggressively over the coming months.

Momentum is starting to build again: CARE has been trending steadily higher while holding above key moving averages, with buyers consistently stepping in on pullbacks.

The stock also remains close to its 52-week highs, which often attracts fresh momentum-focused attention in smaller-cap financial names.

Bear Case 

The market may remain skeptical for longer than expected: The biggest risk is that regional banking sentiment remains permanently damaged in investors' eyes, even if CARE continues to execute reasonably well operationally.

Smaller banks still face pressure from higher funding costs, slower loan growth, and lingering concerns around commercial real estate exposure.

There is also the reality that this is a lower-volume small-cap financial stock.

If the macro backdrop weakens or recession fears return, investors could quickly rotate back out of regional banks regardless of individual fundamentals.

Competing in a difficult regional banking landscape: Carter Bankshares operates in a crowded regional banking market where larger peers like Truist Financial Corporation and First Horizon Corporation have greater scale, broader lending platforms, and significantly larger balance sheets.

The challenge for smaller community-focused banks is that they often need to compete for deposits and lending relationships against institutions with bigger marketing budgets, stronger technology platforms, and more diversified revenue streams.

That pressure can limit valuation expansion if the market continues to favor scale and perceived safety over smaller regional franchises.

Regional banks are still fighting the last crisis: The sector is still dealing with the aftereffects of the regional banking panic, including tighter regulation, elevated deposit competition, and ongoing investor caution around commercial real estate exposure.

Even if CARE executes well individually, sentiment toward smaller financial institutions remains heavily tied to the broader macro environment and interest rate outlook.

Still far from overcrowded: Unlike many of the larger financial names that already saw aggressive recovery buying, CARE still looks relatively underfollowed and lightly owned.

That leaves room for sentiment to improve without the stock feeling excessively crowded yet.

Quick Checklist 

✅ Thesis still valid after today’s close
✅ Volume confirms move above key levels
✅ Catalyst date double-checked (May 18, 2026)

That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned!

Best Regards,
—Noah Zelvis
Everyday Alpha